Almanack Investment Partners, LLC.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1680613
WAYNE, PA
Position in REGN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$404,677
-$2,129,356 QoQ
Shares Held
649
-73.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#860
of 1,322 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Almanack Investment Partners, LLC. holds $2,305,722 across 11 Biotechnology names. REGN ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HYPD |
Hyperion Defi, Inc.
|
169,013 | $530,700 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
649 | $404,677 | |
| 3 | TSHA |
Taysha Gene Therapies, Inc.
|
44,950 | $306,109 | |
| 4 | BHVN |
Biohaven Ltd.
|
17,200 | $255,936 | |
| 5 | MRNA |
Moderna, Inc.
|
3,194 | $223,675 | |
| 6 | RGNX |
REGENXBIO Inc.
|
13,955 | $167,180 | |
| 7 | DTIL |
Precision Biosciences Inc
|
20,428 | $160,564 | |
| 8 | TNYA |
Tenaya Therapeutics, Inc.
|
168,200 | $124,299 |
All Filings in REGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $404,677 | 649 | Shares | Sole | 2026-07-30 | |
| 2024-06-30 | $2,534,033 | 2,411 | Shares | Sole | 2024-10-23 | |
| 2024-03-31 | $5,204,183 | 5,407 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $2,283,554 | 2,600 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $5,266,944 | 6,400 | Shares | Sole | 2023-10-05 | |
| 2023-06-30 | $5,173,488 | 7,200 | Shares | Sole | 2023-10-04 | |
| 2023-03-31 | $4,108,350 | 5,000 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $8,152,837 | 11,300 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||